MedPath

Sarcopenia and Combined-modality Exercise

Not Applicable
Terminated
Conditions
Sarcopenia
Registration Number
NCT04806152
Lead Sponsor
The University of The West Indies
Brief Summary

This study examined the effects of combined-modality exercise training (resistance, endurance, flexibility and balance) on muscle mass, muscle function and physical activity in community-dwelling elderly living in Jamaica who had been characterised as having sarcopenia.

Detailed Description

Community-dwelling seniors aged 60 years and older were screened for muscle mass and function (grip strength and walk speed) and persons with sarcopenia were identified using the European Working Group on Sarcopenia in Older Persons (EWGSOP) algorithm for case finding (N=1344). Of the 77 seniors with sarcopenia, 38 consented to participate and were randomly allocated to receive 6 months combined-modality high intensity treadmill based exercise and a 'usual care' home exercise programme. A comparison of the effects of treatment assignment on muscle mass, function, fitness, physical activity level and disability was done. Participants in the supervised combined-modality high intensity group were required to attend sessions 3 times per week; participants in the home exercise programme were required to attend 1 supervised session at the start of their 6-month intervention. Outcomes were assessed at baseline and at the end of the 6-month intervention. Data were analysed using standard statistical parametric and non-parametric methods including repeated measures analysis of variance to determine changes in outcomes and regression to establish determinants of outcomes.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
38
Inclusion Criteria
  • over 60 years old,
  • independently ambulant, with or without an assistive device
  • mentally competent to give informed consent and follow exercise instructions
Exclusion Criteria
  • a history of stroke with residual disability
  • a diagnosis of cancer
  • neuromuscular disorders
  • auto-immune disorders
  • dementia
  • severe arthritis rendering participation in an exercise programme difficult
  • unstable cardiovascular disease which renders exercise unsafe

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
Lower extremity (LE) functional strength6 months

1-repetition maximum (RM) strength

Appendicular lean mass index6 months

dual energy x-ray absorptiometry (DEXA) measured appendicular lean mass summed and divided by height squared, expressed in kg/m2

Disability6 months

Lawton Instrumental Activities of Daily Living scale: minimum score = 0 (low function, dependent); maximum score = 8 (high function, independent). Lower scores indicate a worse outcome.

Fat-free mass6 months

dual energy x-ray absorptiometry (DEXA) determined: fat mass subtracted from weight, expressed in kg

self-selected walk speed6 months

speed in the timed-10-metre walk

Accelerometry6 months

weekly energy expenditure

Balance6 months

Berg balance test score: minimum score = 0, maximum score = 56. Lower values indicate worse outcome

Functional endurance6 months

Distance walked in 6 minutes

Secondary Outcome Measures
NameTimeMethod
Depression6 months

Center for Epidemiological Studies-Depression \[CES-D\] score: minimum score = 0, maximum score = 60, with higher scores indicating more depressive symptoms

Timed-up-and-go6 months

Functional test indicating fall risk

Trial Locations

Locations (1)

UWI Solutions for Developing Countries (SODECO)

🇯🇲

Kingston 7, KSA, Jamaica

UWI Solutions for Developing Countries (SODECO)
🇯🇲Kingston 7, KSA, Jamaica

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.